INSIGHT-AI+ Study will commence in the coming months. It will be a prospective study to validate the diagnostic accuracy of the AngioAI+ System.

The study will be led by the Co-Primary Investigators, Dr. Todd Villines of UVA and Dr. Carlos Collet, Of Olv Hospital in Aalst, Belgium. We expect to have approximately 25 centers in both the US & EU.

If you are interested in learning more or being a site in the study, please contact us at info@angioinsight.com.